STOK
Price
$29.03
Change
-$0.31 (-1.06%)
Updated
Sep 11 closing price
Capitalization
1.87B
59 days until earnings call
Intraday BUY SELL Signals
TSHA
Price
$5.02
Change
-$0.14 (-2.71%)
Updated
Sep 11 closing price
Capitalization
1.64B
59 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

STOK vs TSHA

STOK vs TSHA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
STOK vs. TSHA commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STOK is a StrongBuy and TSHA is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($1.87B) has a higher market cap than TSHA($1.64B). STOK has higher P/E ratio than TSHA: STOK (48.34) vs TSHA (2.70). STOK (-8.538) and TSHA (-8.727) have similar YTD gains . TSHA has higher annual earnings (EBITDA): -148.42M vs. STOK (-221.63M). TSHA has more cash in the bank: 455M vs. STOK (293M). STOK has less debt than TSHA: STOK (1.85M) vs TSHA (56.7M). STOK has higher revenues than TSHA: STOK (27.6M) vs TSHA (5.49M).
STOKTSHASTOK / TSHA
Capitalization1.87B1.64B114%
EBITDA-221.63M-148.42M149%
Gain YTD-8.538-8.72798%
P/E Ratio48.342.701,791%
Revenue27.6M5.49M503%
Total Cash293M455M64%
Total Debt1.85M56.7M3%
FUNDAMENTALS RATINGS
STOK vs TSHA: Fundamental Ratings
STOK
TSHA
OUTLOOK RATING
1..100
6552
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
90100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
5958
P/E GROWTH RATING
1..100
398
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TSHA's Valuation (62) in the null industry is in the same range as STOK (86). This means that TSHA’s stock grew similarly to STOK’s over the last 12 months.

STOK's Profit vs Risk Rating (90) in the null industry is in the same range as TSHA (100). This means that STOK’s stock grew similarly to TSHA’s over the last 12 months.

STOK's SMR Rating (98) in the null industry is in the same range as TSHA (98). This means that STOK’s stock grew similarly to TSHA’s over the last 12 months.

TSHA's Price Growth Rating (58) in the null industry is in the same range as STOK (59). This means that TSHA’s stock grew similarly to STOK’s over the last 12 months.

STOK's P/E Growth Rating (3) in the null industry is significantly better than the same rating for TSHA (98). This means that STOK’s stock grew significantly faster than TSHA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STOKTSHA
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 19 days ago
88%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (STOK: $29.03 vs. TSHA: $5.02)
Brand notoriety: STOK and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: STOK: 80% vs. TSHA: 74%
Market capitalization -- STOK: $1.87B vs. TSHA: $1.64B
STOK [@Biotechnology] is valued at $1.87B. TSHA’s [@Biotechnology] market capitalization is $1.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STOK’s FA Score shows that 1 FA rating(s) are green while TSHA’s FA Score has 0 green FA rating(s).

  • STOK’s FA Score: 1 green, 4 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, STOK is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STOK’s TA Score shows that 3 TA indicator(s) are bullish while TSHA’s TA Score has 2 bullish TA indicator(s).

  • STOK’s TA Score: 3 bullish, 6 bearish.
  • TSHA’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, STOK is a better buy in the short-term than TSHA.

Price Growth

STOK (@Biotechnology) experienced а -2.62% price change this week, while TSHA (@Biotechnology) price change was -10.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

STOK is expected to report earnings on Nov 10, 2026.

TSHA is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
STOK
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NMAR32.720.13
+0.40%
Innovator Growth-100 Pwr Buffr ETF - Mar
AQWA18.310.03
+0.18%
Global X Clean Water ETF
BWZ27.390.03
+0.11%
State Street® SPDR® BlmbgSTIntrnTrsBdETF
LDRC24.80N/A
N/A
iShares iBonds 1-5 Year Corporate Ladder ETF
EVSD50.35-0.07
-0.14%
Eaton Vance Short Duration Income ETF

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with NGNE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-2.71%
NGNE - TSHA
47%
Loosely correlated
-1.77%
PRME - TSHA
46%
Loosely correlated
-6.57%
STOK - TSHA
44%
Loosely correlated
-1.06%
MGTX - TSHA
43%
Loosely correlated
-0.47%
ABEO - TSHA
43%
Loosely correlated
-1.19%
More